| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07325292 Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous… |
Trial sites expanded: 34 -> 38 locations |
| 2026-08-15 | NCT04401020 First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL |
critical overall status: Completed → Terminated |
| 2026-08-15 | NCT04401020 First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL |
critical Trial terminated: Sponsor decision based on limited clinical benefit observed in both Multiple Myeloma and Non-Hodgkin Lymphoma cohorts |
| 2026-08-14 | NCT07556159 A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in… |
Trial sites expanded: 54 -> 59 locations |
| 2026-08-14 | NCT06192563 A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less… |
Primary endpoint(s) modified |
| 2026-08-14 | NCT06192563 A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less… |
Enrollment increased: 150 -> 230 participants |
| 2026-08-14 | NCT06191315 Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic… |
overall status: Recruiting → Enrolling by Invitation |
| 2026-08-14 | NCT07484230 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… |
critical Withdrawn before enrolling |
| 2026-08-14 | NCT07484230 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… |
critical Trial withdrawn: Sponsor decision. Not related to safety concern. |
| 2026-08-14 | NCT07484230 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… |
Enrollment reduced: 20 -> 0 participants |
| 2026-08-13 | NCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in… |
overall status: Enrolling by Invitation → Active, Not Recruiting |
| 2026-08-13 | NCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in… |
Enrollment reduced: 380 -> 59 participants |
| 2026-08-13 | NCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in… |
date change Primary completion moved earlier: 2028-12-12 -> 2027-02-17 |
| 2026-08-13 | NCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in… |
date change Completion moved earlier: 2028-12-12 -> 2027-02-17 |
| 2026-08-11 | NCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… |
Enrollment reduced: 140 -> 109 participants |
| 2026-08-11 | NCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… |
date change Primary completion moved earlier: 2027-05-17 -> 2026-06-10 |
| 2026-08-11 | NCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… |
date change Completion moved earlier: 2028-11-20 -> 2027-10-31 |
| 2026-08-11 | NCT07688213 A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With… |
Recruitment opened |
| 2026-08-11 | NCT07634692 An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07756957 Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to… | Phase 2 | Not Yet Recruiting |
| 2026-07-29 | NCT07734649 Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV)… | Phase 1/2 | Recruiting |
| 2026-07-29 | NCT07734753 Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic… | Active, Not Recruiting | |
| 2026-07-24 | NCT07726914 Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06941870 | Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy | Factor VIII Deficiency | Recruiting |
| NCT06671587 | iGlarLixi CGM Study in Chinese T2D Individuals After OADs | Type 2 Diabetes (T2D) | Recruiting |
| NCT06666413 | China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With… | Glycogen Storage Disease Type II | Recruiting |
| NCT06145373 | A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe… | Hemophilia A | Recruiting |
| NCT07053423 | A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07286214 | Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica | Polymyalgia Rheumatica | Recruiting |
| NCT05164055 | Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA… | Glycogen Storage Disease Type II | Active, Not Recruiting |
| NCT06101095 | A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo… | Eosinophilic Oesophagitis | Active, Not Recruiting |
| NCT05757713 | Teplizumab in Pediatric Stage 2 Type 1 Diabetes | Diabetes Mellitus, Type 1 | Active, Not Recruiting |
| NCT07109297 | Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in… | RSV Immunization | Active, Not Recruiting |
| NCT05983068 | A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric… | Dermatitis Atopic | Active, Not Recruiting |
| NCT05097287 | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline… | Asthma | Active, Not Recruiting |
| NCT07135973 | A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above… | Chronic Graft Versus Host Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT06293053 | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6… | Prurigo Nodularis | Recruiting |
| NCT07247188 | Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and… | Sickle Cell Disease | Recruiting |
| NCT07184996 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Ulcerative Colitis | Recruiting |
| NCT07103148 | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | Yellow Fever Immunization | Recruiting |
| NCT07348692 | Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy… | Pneumococcal Immunization | Recruiting |
| NCT07086976 | A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib… | Autoimmune Haemolytic Anaemia | Recruiting |
| NCT07190209 | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07190222 | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07007962 | Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune… | Immune Thrombocytopenia | Recruiting |
| NCT07184944 | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Crohn's Disease | Recruiting |
| NCT07285460 | A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male… | Hemophilia | Recruiting |
| NCT06082037 | A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants… | Lung Transplant Rejection | Recruiting |